Adcock Ingram Holdings Limited (AIP.JO)

ZAc 6501.0

(-3.33%)

Market Cap (In ZAc)

10.51 Billion

Revenue (In ZAc)

9.64 Billion

Net Income (In ZAc)

814 Million

Avg. Volume

35.75 Thousand

Currency
ZAc
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5115.0-10040.858
PE
-
EPS
-
Beta Value
0.341
ISIN
ZAE000123436
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Andrew Gideon Hall CA (SA), BPharm
Employee Count
-
Website
https://www.adcock.co.za
Ipo Date
2000-03-06
Details
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.